Clinical Trials Directory

We are doing this study to find out if an investigational drug called Rusfertide (the study drug) is a safe and effective treatment for polycythemia vera (PV). Rusfertide (also known as PTG-300) lowers the level of iron in the blood which is required for production of red blood cells.

We are doing this study to find out if an experimental drug called birtamimab (the study drug) is a safe and effective treatment for amyloidosis. We want to find the most appropriate dose and schedule to give patients the study drug.

We are doing this study to measure quality of life and compare signs such as tiredness, feeling of unease and discomfort in the stomach and pain in patients who have been treated with either PLA or HIGRT for liver cancer.

We are doing this study to learn if a new study drug called PT-112 is a safe and effective treatment for metastatic, castrate-resistant prostate cancer. This study is one of the first times PT-112 is being tested in humans. The study drug has been shown to induce cell death in tumor cells, and shrink tumors in animal studies. This study will also teach us how long the study drug stays in your body after you receive it.

We created this registry for people with rare breast tumors to help us learn more about them and how to better treat people in the future.

We are doing the study to understand how your body reacts to the study drug, Cemiplimab.

We are doing this study to find out the safest and most effective dose of the study drug (RP-3500) is when given alone or in combination with talazoparib.

We are doing this study to find out if an experimental study drug called RP1 is a safe and effective treatment for your cancer. We want to know how the drug works on its own and when it is combined with a cancer drug called nivolumab.